• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 021995 Product 003 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N021995 003 6303661 Apr 24, 2017 U - 774
N021995 003 6699871 Jul 26, 2022 Y Y U - 774
N021995 003 6890898 Feb 2, 2019 U - 775
N021995 003 6890898 Feb 2, 2019 U - 1036
N021995 003 6890898 Feb 2, 2019 U - 1039
N021995 003 7078381 Feb 2, 2019 U - 775
N021995 003 7078381 Feb 2, 2019 U - 1037
N021995 003 7078381 Feb 2, 2019 U - 1036
N021995 003 7078381 Feb 2, 2019 U - 1038
N021995 003 7125873 Jul 26, 2022 U - 775
N021995 003 7125873 Jul 26, 2022 U - 1036
N021995 003 7125873 Jul 26, 2022 U - 1038
N021995 003 7125873 Jul 26, 2022 U - 1037
N021995 003 7326708 Apr 11, 2026 Y Y U - 802

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through October 2014
Patent and Generic Drug Product Data Last Updated November 21, 2014

-
-